Vladimir N. Kashnikov

Vladimir N. Kashnikov

Auto-generated profile, based on publicly available information

Vladimir N. Kashnikov

Ryzhikh National Medical Research Centre for Coloproctology

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2022 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
VIVladimir Ivashkin
Vladimir Ivashkin
IMI. V. Maev
I. V. Maev
YSYu. A. Shelygin
Yu. A. Shelygin
EBE. K. Baranskaya
E. K. Baranskaya
SBS. S. Belous
S. S. Belous
Vladislav Vladimirovich TsukanovVladislav Vladimirovich Tsukanov
Vladislav Vladimirovich Tsukanov
Aim. Current clinical recommendations accentuate current methods for the diagnosis and treatment of irritable bowel syndrome (IBS).Key points.IBS is a functional bowel disorder manifested with recurrent, at least weekly, abdominal pain with the following attributes (any two leastwise): link to defecation, its frequency or stool shape. The symptoms are expected to persist for at minimum three months in a total six-month follow-up. Similar to other functional gastrointestinal (GI) disorders, IBS can be diagnosed basing on the patient symptoms compliance with Rome IV criteria, provided the absence of potentially symptom-causative organic GI diseases. Due to challenging differential diagnosis, IBS can be appropriately established per exclusionem, with pre-examination as follows: general and biochemical blood tests; tissue transglutaminase IgA/IgG antibody tests; thyroid hormones test; faecal occult blood test; hydrogen glucose/ lactulose breath test for bacterial overgrowth; stool test for enteric bacterial pathogens and Clostridium difficile A/B toxins; stool calprotectin test; abdominal ultrasound; OGDS, with biopsy as appropriate; colonoscopy with biopsy. The IBS sequence is typically wavelike, with alternating remissions and exacerbations often triggered by psychoemotional stress. Treatment of IBS patients includes dietary and lifestyle adjustments, various-class drug agents prescription and psychotherapeutic measures.Conclusion. Adherence to clinical recommendations can facilitate timely diagnosis and improve medical aid quality in patients with different clinical IBS variants.

18 January 2019 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
ATAleksey Tsukanov
Aleksey Tsukanov
VSVitaly Shubin
Vitaly Shubin
АКА. М. Кузьминов
А. М. Кузьминов
MTM. Kh. Toboeva
M. Kh. Toboeva
TST. A. Savelyeva
T. A. Savelyeva
YSYu. A. Shelygin
Yu. A. Shelygin
Aim. In this research, we aim to develop a criterion for differentiating MutYH-associated polyposis from sporadic colon polyps.Materials and methods. A search for mutations in the MutYH gene was carried out using the PCR, electrophoresis and direct sequencing methods among the following groups of people: 18 patients under 45 years old with more than 100 polyps diagnosed in the large intestine; 86 patients over 45 years old with 4–100 polyps; 150 people of the control group.Results. Mutations in the MutYH gene were detected in 2 out of 18 patients having more than 100 polyps. Among 86 patients with 4–100 polyps, mutations were found in 10 people having more than 20 polyps. Mutations in the MutYH gene were not detected in patients with 4–19 polyps (p <0.05). The pathogenic significance of the disease development was established not only for biallelic, but also for monoallelic mutations.Conclusion. For the first time, the lower limit of the polyp number has been established, allowing the MutYH-associated polyposis to be differentiated from sporadic polyps.

15 December 2020 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
OFO. Yu. Fomenko
O. Yu. Fomenko
SMSergey Morozov
Sergey Morozov
MSMark Scott
Mark Scott
CKCharles Knowles
Charles Knowles
DMD. A. Morozov
D. A. Morozov
КАКучерявый Юрий Александрович
Кучерявый Юрий Александрович
This manuscript summarizes consensus reached by the International Anorectal Physiology Working Group (IAPWG) for the performance, terminology used, and interpretation of anorectal function testing including anorectal manometry (focused on high-resolution manometry), the rectal sensory test, and the balloon expulsion test. Based on these measurements, a classification system for disorders of anorectal function is proposed. Aim to provide information about methods of diagnosis and new classification of functional anorectal disorders to a wide range of specialists general practitioners, therapists, gastroenterologists, coloproctologists all who face the manifestations of these diseases in everyday practice and determine the diagnostic and therapeutic algorithm. Current paper provides agreed statements of IAPWG Consensus and comments (in italics) of Russian experts on real-world practice, mainly on methodology of examination. These comments in no way intended to detract from the provisions agreed by the international group of experts. We hope that these comments will help to improve the quality of examination based on the systematization of local experience with the use of the methods discussed and the results obtained. Key recommendations: the International Anorectal Physiology Working Group protocol for the performance of anorectal function testing recommends a standardized sequence of maneuvers to test rectoanal reflexes, anal tone and contractility, rectoanal coordination, and rectal sensation. Major findings not seen in healthy controls defined by the classification are as follows: rectoanal areflexia, anal hypotension and hypocontractility, rectal hyposensitivity, and hypersensitivity. Minor and inconclusive findings that can be present in health and require additional information prior to diagnosis include anal hypertension and dyssynergia.

25 November 2022 in Koloproktologia
Verified
Journal Article
Open access
PDF file
OFO. Yu. Fomenko
O. Yu. Fomenko
SMSergey Morozov
Sergey Morozov
YSYu. A. Shelygin
Yu. A. Shelygin
DND. B. Nikityuk
D. B. Nikityuk
GPG. V. Poryadin
G. V. Poryadin
SASergey I. Achkasov
Sergey I. Achkasov
This paper presents interdisciplinary consensus on the use of protocols of high-intensity magnetic stimulation for the treatment of pelvic floor muscles dysfunction with anal incontinence in Russia.AIM: to highlight the discussion and the decision-making on the basis of an interdisciplinary consensus on the use of a new algorithm of peripheral and transcranial magnetic stimulation in the treatment of pelvic floor muscles dysfunction with the clinic of anal incontinence.RESULTS: the adoption of this consensus can serve as a basis for further research of this problem and optimize the results of treatment of patients with pelvic floor muscle dysfunction with anal incontinence. The data may be interesting for a wide range of medical specialists: general practitioners, gastroenterologists, coloproctologists, surgeons, neurosurgeons, gynecologists, urologists — anyone who encounter with manifestations of this disorder in a routine practice and chooses diagnostic and treatment options.CONCLUSION: protocols for the treatment of anal incontinence using high-intensity magnetic stimulation aimed at improving the quality of treatment of patients with anal incontinence are based on the Russian experience of using the methods discussed and the analysis of the results obtained are validated.

17 May 2019 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
ATAleksey Tsukanov
Aleksey Tsukanov
YSYury A. Shelygin
Yury A. Shelygin
SASergey I. Achkasov
Sergey I. Achkasov
СФСергей Алексеевич Фролов
Сергей Алексеевич Фролов
ВКВладимир Николаевич Кашников
Владимир Николаевич Кашников
АЦАлексей Сергеевич Цуканов
Алексей Сергеевич Цуканов
The most frequent forms of hereditary colorectal cancer syndromes are Lynch syndrome and familial adenomatous polyposis (FAP). All the patients with suspicion to these syndromes need precise clinical and genetic diagnostics. Affected patients need personalized program of treatment because standard algorithm cannot be considered sufficiently effective. Identification of a pathogenic mutation in a patient indicates the need for DNA diagnostics in his close relatives and only in this case all the carriers of pathogenic germline mutations can be included in the high-risk group. Algorithms of clinical monitoring and operative treatment for mutation carriers were developed in different countries. However, different populations have their own genetic and clinical features. The aim of this work was to highlight the principles of diagnosis and personalized treatment of patients with hereditary colorectal cancer, taking into account international and Russian recommendations.

1 January 2017 in Voprosy onkologii
Verified
Journal Article
Open access
PDF file
ATAleksey Tsukanov
Aleksey Tsukanov
VSVitaly Shubin
Vitaly Shubin
NPNatalya Pospekhova
Natalya Pospekhova
SASergey I. Achkasov
Sergey I. Achkasov
DSDmitriy Semenov
Dmitriy Semenov
YSYuriy Shelygin
Yuriy Shelygin
Lynch syndrome is a hereditary colorectal cancer syndrome caused by mutations in the DNA repair system genes. We studied the clinical and genetic characteristics of 27 Russian patients with Lynch syndrome. Germinal mutations were found in genes MLH1 (14 patients), MSH2 (11 patients) and MSH6 (2 patients). Eight mutations have not been described previously. The clinical features of this group of patients consisted of early average age of the first cancer - 36.7 years, predominant (72.4%) damage of the left colon, occurs most (70.6%) metachronous tumors for 10 years after the previous surgery, high (53.6%) frequency of poorly differentiated adenocarcinomas. The described genetic and phenotypic pattern indicates a need for more targeted selection of patients with suspected Lynch syndrome as well as the feasibility of the development of clinical guidelines for monitoring and surgical treatment exactly Russian patients. Синдром Линча - наследственный колоректальный раковый синдром, обусловленный мутациями в генах системы репарации ДНК. Исследованы клинико-генетические характеристики 27 российских пациентов с синдромом Линча. Герминальные мутации обнаружены в генах MLH1 (у 14 больных), MSH2 (у 11 человек) и MSH6 (у 2 пациентов). Восемь мутаций не были описаны ранее. Клинические особенности этой группы российских пациентов заключались в раннем среднем возрасте развития первого рака - 36,7 лет; преимущественном (72,4%) поражении левых отделов толстой кишки; возникновении большинства (70,6%) метахронных опухолей в течение 10 лет после предыдущей операции; высокой (53,6%) частоте низкодифференцированных аденокарцином. Описанная генетико-фенотипическая картина указывает на необходимость более прицельного отбора пациентов с подозрением на синдром Линча, а также целесообразность разработки клинических рекомендаций по мониторингу и оперативному лечению именно российских больных.